Skip to Content

APO MOE 7.5 (Moexipril Hydrochloride 7.5 mg)

Pill with imprint APO MOE 7.5 is White, Round and has been identified as Moexipril Hydrochloride 7.5 mg. It is supplied by Apotex Corp..

Moexipril is used in the treatment of diabetic kidney disease; heart attack; heart failure; high blood pressure; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO MOE 7.5

Moexipril hydrochloride 7.5 mg APO MOE 7.5
Moexipril hydrochloride 7.5 mg APO MOE 7.5
Moexipril hydrochloride 7.5 mg APO MOE 7.5

Moexipril Hydrochloride

Imprint
APO MOE 7.5
Strength
7.5 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-0271
Inactive Ingredients
magnesium carbonate, crospovidone, copovidone, zinc stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.